Middle East & Africa Gastric Cancer Diagnostics Market to 2032
Overview
The Middle East & Africa Gastric Cancer Diagnostics Market is expected to reach a 72.46 USD Million by 2032 and is projected to grow at a CAGR of 8.84% from 2025 to 2032.
Revenue, 2024 (USD Million)
44.21
Forecast, 2032 (USD Million)
72.46
CAGR, 2024 - 2032
8.84%
Report Coverage
Middle East & Africa
Middle East & Africa Gastric Cancer Diagnostics Market 2018-2032 USD Million
Middle East & Africa Gastric Cancer Diagnostics Market, Key Findings (2025-2032)
Market Growth and Projections:
- Market Size (2024): 44.21 USD Million
- Projected Market Size (2032): 72.46 USD Million
- CAGR (2025-2032): 8.84%
Key Findings of Middle East & Africa Gastric Cancer Diagnostics Market
- The Middle East & Africa Gastric Cancer Diagnostics Market was valued at 44.21 USD Million in 2024.
- The Middle East & Africa Gastric Cancer Diagnostics Market is likely to grow at a CAGR of 8.84% during the forecast period of 2024 to 2032.
- In 2024, the Largest segment Direct Tender in Distribution Channel Segment accounted for the largest share of the market with a revenue of 28.13 USD Million
- The fastest growing segment Hospitals in End User Segment grew Fastest with a CAGR of 11.84% during the forecast period from 2024 to 2032.
Middle East & Africa Gastric Cancer Diagnostics Market Scope
Middle East & Africa Gastric Cancer Diagnostics Market Segmentation & Scope
End User
- Others
- Oncology Speciality Clinics
- Cancer Research Institutes
- Diagnostic Laboratories
- Hospitals
Distribution Channel
- Retail Sales
- Direct Tender
Sample Type
- Urine
- Blood
- Tissue
- Stool
Disease Type
- Others
- Gastric Lymphoma
- Gastrointestinal Stromal Tumor
- Carcinoid tumor
- Intestinal or Diffuse Adinocarcinoma
Stage
- Stage 0
- Stage III
- Stage II
- Stage I
Gender
- Female
- Male
Age Group
- Pediatric
- Adult
- Geriatrics
Product Type
- Services
- Instruments
- Reagents & Consumables
Diagnostic Type
- Gastric Cancer Screening Tests/Physical Exam
- Confirmatory Test
Middle East & Africa Gastric Cancer Diagnostics Market Data Coverage Insights
| Study Period | 2024-2032 |
| Base Year | 2020 |
| Unit | Revenue in USD Million |
| Market Value in 2024 | 44.21 USD Million |
| Market Value in 2032 | 72.46 USD Million |
| CAGR (2025-2032) | 8.84% |
| Historic Data | 2016-2023 |
| Market Segments Covered | End User,Distribution Channel,Sample Type,Disease Type,Stage,Gender,Age Group,Product Type,Diagnostic Type |
Regional Insights:
-
Leading Market (2024-2032): Middle East & Africa, leading in terms of revenue 44.21 USD Million in 2024
- Key Country: South Africa, leading in terms of revenue with value of 17.21 USD Million in 2024.
Segments and Scope
-
Middle East & Africa Gastric Cancer Diagnostics Market to 2032, By End User
- Hospitals is the largest segment in Middle East & Africa Gastric Cancer Diagnostics Market to 2032 with a revenue of 15.43 USD Million in the year 2024.
- Hospitals is the Fastest growing segment in Middle East & Africa Gastric Cancer Diagnostics Market to 2032 with a Growth rate of 11.84 % in forecast period 2025-2032.
-
Middle East & Africa Gastric Cancer Diagnostics Market to 2032, By Distribution Channel
- Direct Tender is the largest segment in Middle East & Africa Gastric Cancer Diagnostics Market to 2032 with a revenue of 28.13 USD Million in the year 2024.
- Direct Tender is the Fastest growing segment in Middle East & Africa Gastric Cancer Diagnostics Market to 2032 with a Growth rate of 9.82 % in forecast period 2025-2032.
-
Middle East & Africa Gastric Cancer Diagnostics Market to 2032, By Sample Type
- Stool is the largest segment in Middle East & Africa Gastric Cancer Diagnostics Market to 2032 with a revenue of 18.15 USD Million in the year 2024.
- Stool is the Fastest growing segment in Middle East & Africa Gastric Cancer Diagnostics Market to 2032 with a Growth rate of 11.76 % in forecast period 2025-2032.
-
Middle East & Africa Gastric Cancer Diagnostics Market to 2032, By Disease Type
- Intestinal or Diffuse Adinocarcinoma is the largest segment in Middle East & Africa Gastric Cancer Diagnostics Market to 2032 with a revenue of 19.40 USD Million in the year 2024.
- Intestinal or Diffuse Adinocarcinoma is the Fastest growing segment in Middle East & Africa Gastric Cancer Diagnostics Market to 2032 with a Growth rate of 11.07 % in forecast period 2025-2032.
-
Middle East & Africa Gastric Cancer Diagnostics Market to 2032, By Stage
- Stage I is the largest segment in Middle East & Africa Gastric Cancer Diagnostics Market to 2032 with a revenue of 16.84 USD Million in the year 2024.
- Stage I is the Fastest growing segment in Middle East & Africa Gastric Cancer Diagnostics Market to 2032 with a Growth rate of 11.25 % in forecast period 2025-2032.
-
Middle East & Africa Gastric Cancer Diagnostics Market to 2032, By Gender
- Male is the largest segment in Middle East & Africa Gastric Cancer Diagnostics Market to 2032 with a revenue of 23.73 USD Million in the year 2024.
- Male is the Fastest growing segment in Middle East & Africa Gastric Cancer Diagnostics Market to 2032 with a Growth rate of 9.73 % in forecast period 2025-2032.
-
Middle East & Africa Gastric Cancer Diagnostics Market to 2032, By Age Group
- Geriatrics is the largest segment in Middle East & Africa Gastric Cancer Diagnostics Market to 2032 with a revenue of 23.79 USD Million in the year 2024.
- Geriatrics is the Fastest growing segment in Middle East & Africa Gastric Cancer Diagnostics Market to 2032 with a Growth rate of 11.01 % in forecast period 2025-2032.
-
Middle East & Africa Gastric Cancer Diagnostics Market to 2032, By Product Type
- Reagents & Consumables is the largest segment in Middle East & Africa Gastric Cancer Diagnostics Market to 2032 with a revenue of 24.74 USD Million in the year 2024.
- Reagents & Consumables is the Fastest growing segment in Middle East & Africa Gastric Cancer Diagnostics Market to 2032 with a Growth rate of 10.72 % in forecast period 2025-2032.
-
Middle East & Africa Gastric Cancer Diagnostics Market to 2032, By Diagnostic Type
- Confirmatory Test is the largest segment in Middle East & Africa Gastric Cancer Diagnostics Market to 2032 with a revenue of 25.60 USD Million in the year 2024.
- Confirmatory Test is the Fastest growing segment in Middle East & Africa Gastric Cancer Diagnostics Market to 2032 with a Growth rate of 9.84 % in forecast period 2025-2032.
Middle East & Africa Gastric Cancer Diagnostics Market Company Share Analysis
| Company Name |
|
||
| Myriad Genetics, Inc. | |||
| BIOMÉRIEUX | |||
| Abbott | |||
| General Electric | |||
| F. Hoffmann-La Roche Ltd. | |||
Middle East & Africa Gastric Cancer Diagnostics Market Geographical Sales Distribution, 2018-2032 USD Million
Middle East & Africa Gastric Cancer Diagnostics Market Company Profiling
Industry Related Reports
Frequently Asked Questions
The Middle East & Africa Gastric Cancer Diagnostics Market is segmented based on Segmentation End User,Distribution Channel,Sample Type,Disease Type,Stage,Gender,Age Group,Product Type,Diagnostic Type.
Middle East & Africa Gastric Cancer Diagnostics Market was valued at USD 44.21(Revenue in USD Million) in 2020.
Middle East & Africa Gastric Cancer Diagnostics Market is projected to grow at a CAGR of 8.84% during the forecast period of 2024 to 2032.
The Direct Tender segment is expected to dominate the Middle East & Africa Gastric Cancer Diagnostics Market, holding a largest market share of 28.13 USD Million in 2024
Middle East & Africa Gastric Cancer Diagnostics Market Scope
Middle East & Africa Gastric Cancer Diagnostics Market Segmentation & Scope
End User
- Others
- Oncology Speciality Clinics
- Cancer Research Institutes
- Diagnostic Laboratories
- Hospitals
Distribution Channel
- Retail Sales
- Direct Tender
Sample Type
- Urine
- Blood
- Tissue
- Stool
Disease Type
- Others
- Gastric Lymphoma
- Gastrointestinal Stromal Tumor
- Carcinoid tumor
- Intestinal or Diffuse Adinocarcinoma
Stage
- Stage 0
- Stage III
- Stage II
- Stage I
Gender
- Female
- Male
Age Group
- Pediatric
- Adult
- Geriatrics
Product Type
- Services
- Instruments
- Reagents & Consumables
Diagnostic Type
- Gastric Cancer Screening Tests/Physical Exam
- Confirmatory Test
Frequently Asked Questions
The Middle East & Africa Gastric Cancer Diagnostics Market is segmented based on Segmentation End User,Distribution Channel,Sample Type,Disease Type,Stage,Gender,Age Group,Product Type,Diagnostic Type.
Middle East & Africa Gastric Cancer Diagnostics Market was valued at USD 44.21(Revenue in USD Million) in 2020.
Middle East & Africa Gastric Cancer Diagnostics Market is projected to grow at a CAGR of 8.84% during the forecast period of 2024 to 2032.
The estimated market value of the Middle East & Africa Gastric Cancer Diagnostics Market for final year is USD 72.46 (USD Million).
Middle East & Africa Gastric Cancer Diagnostics Market Company Profiling
Frequently Asked Questions
The Middle East & Africa Gastric Cancer Diagnostics Market is segmented based on Segmentation End User,Distribution Channel,Sample Type,Disease Type,Stage,Gender,Age Group,Product Type,Diagnostic Type.
Middle East & Africa Gastric Cancer Diagnostics Market was valued at USD 44.21(Revenue in USD Million) in 2020.
Middle East & Africa Gastric Cancer Diagnostics Market is projected to grow at a CAGR of 8.84% during the forecast period of 2024 to 2032.
The estimated market value of the Middle East & Africa Gastric Cancer Diagnostics Market for final year is USD 72.46 (USD Million).
CHOOSE LICENCE TYPE
- 4200.00
- 3500.00
- 2000.00
- 5500.00
- 8500.00
HAVE A QUESTION?
Get expert advice on the right strategy for your business at no cost. We also offer customized subscription plans and affordable discounts for startups and universities.